Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2018 1
2021 2
2022 5
2023 0

Text availability

Article attribute

Article type

Publication date

Search Results

7 results

Results by year

Filters applied: . Clear all
Page 1
Seroprevalence of the SARS-CoV-2 antibody in healthcare workers: a multicentre cross-sectional study in 10 Colombian cities.
Malagón-Rojas JN, Mercado-Reyes M, Toloza-Pérez YG, Parra Barrera EL, Palma M, Muñoz E, López R, Almentero J, Rubio VV, Ibáñez E, Téllez E, Delgado-Murcia LG, Jimenez CP, Viasus-Pérez D, Galindo M, Lagos L; Interinstitutional Support Group. Malagón-Rojas JN, et al. Among authors: galindo m. Occup Environ Med. 2022 Jun;79(6):388-395. doi: 10.1136/oemed-2021-107487. Epub 2021 Nov 5. Occup Environ Med. 2022. PMID: 34740981 Free PMC article.
Seroprevalence of SARS-CoV-2 Antibodies in Children and Adolescents: Results From a Population-Based Survey in 10 Colombian Cities.
Mercado-Reyes MM, Daza M, Pacheco A, Meneses-Gil MX, Galindo M, Catama J, Botero LS, Muñoz L, Quinche G, Ospina ML. Mercado-Reyes MM, et al. Among authors: galindo m. Glob Pediatr Health. 2022 Mar 21;9:2333794X221085385. doi: 10.1177/2333794X221085385. eCollection 2022. Glob Pediatr Health. 2022. PMID: 35342777 Free PMC article.
Low Neutralizing Antibody Titers against the Mu Variant of SARS-CoV-2 in 31 BNT162b2 Vaccinated Individuals in Colombia.
Álvarez-Díaz DA, Muñoz AL, Tavera-Rodríguez P, Herrera-Sepúlveda MT, Ruiz-Moreno HA, Laiton-Donato K, Franco-Muñoz C, Pelaez-Carvajal D, Cuellar D, Muñoz-Suarez AM, Galindo M, Arias-Ramírez EJ, Mercado-Reyes M. Álvarez-Díaz DA, et al. Among authors: galindo m. Vaccines (Basel). 2022 Jan 24;10(2):180. doi: 10.3390/vaccines10020180. Vaccines (Basel). 2022. PMID: 35214639 Free PMC article.
Neutralizing Antibody Responses Elicited by Inactivated Whole Virus and Genetic Vaccines against Dominant SARS-CoV-2 Variants during the Four Epidemic Peaks of COVID-19 in Colombia.
Álvarez-Díaz DA, Muñoz AL, Herrera-Sepúlveda MT, Tavera-Rodríguez P, Laiton-Donato K, Franco-Muñoz C, Ruiz-Moreno HA, Galindo M, Catama JD, Bermudez-Forero A, Mercado-Reyes M. Álvarez-Díaz DA, et al. Among authors: galindo m. Vaccines (Basel). 2022 Dec 14;10(12):2144. doi: 10.3390/vaccines10122144. Vaccines (Basel). 2022. PMID: 36560554 Free PMC article.
Comparison of Anti-SARS-CoV-2 IgG Antibody Responses Generated by the Administration of Ad26.COV2.S, AZD1222, BNT162b2, or CoronaVac: Longitudinal Prospective Cohort Study in the Colombian Population, 2021/2022.
Malagón-Rojas J, Mercado-Reyes M, Toloza-Pérez YG, Galindo M, Palma RM, Catama J, Bedoya JF, Parra-Barrera EL, Meneses X, Barbosa J, Tavera-Rodríguez P, Bermúdez-Forero A, Ospina-Martínez ML. Malagón-Rojas J, et al. Among authors: galindo m. Vaccines (Basel). 2022 Sep 26;10(10):1609. doi: 10.3390/vaccines10101609. Vaccines (Basel). 2022. PMID: 36298474 Free PMC article.